Cost-Effectiveness of Telaprevir Plus Peginterferon/Ribavirin (TVR+PR) Versus Peginterferon/Ribavirin (PR) in Treatment-Naïve Genotype 1 Chronic Hepatitis C Patients with F2 Fibrosis in Brazil

Value in Health ◽

10.1016/j.jval.2013.08.185 ◽

2013 ◽

Vol 16 (7) ◽

pp. A354

Author(s):

A.D. Morais ◽

M.L. Pereira

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Treatment Naïve ◽

Chronic Hepatitis C Patients

Download Full-text

PIN62 Cost-Effectiveness of Triple Therapy With Telaprevir for the Treatment of Treatment-Naïve Genotype 1 Chronic Hepatitis C Patients in Germany

Value in Health ◽

10.1016/j.jval.2012.08.1129 ◽

2012 ◽

Vol 15 (7) ◽

pp. A396

Author(s):

J.T. Stahmeyer ◽

S. Schauer ◽

D. Wirth ◽

J. Fleischmann ◽

S. Lee ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

Treatment Naïve ◽

Chronic Hepatitis C Patients

Download Full-text

Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options

Journal of Viral Hepatitis ◽

10.1111/jvh.12278 ◽

2014 ◽

Vol 22 (2) ◽

pp. 175-183 ◽

Author(s):

P. A. Cortesi ◽

A. Ciaccio ◽

M. Rota ◽

J. K. Lim ◽

S. De Salvia ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Treatment Options ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Treatment Naïve

Download Full-text

1170 PREDICTORS OF DAYS UNABLE TO WORK AMONG GENOTYPE 1 TREATMENT-NAIVE CHRONIC HEPATITIS C PATIENTS: POST-HOC ANALYSES OF DATA FROM PHASE 3 ADVANCE AND ILLUMINATE STUDIES

Journal of Hepatology ◽

10.1016/s0168-8278(12)61182-9 ◽

2012 ◽

Vol 56 ◽

pp. S463

Author(s):

N. Hernandez ◽

M. Vera-Llonch ◽

J. Aggarwal ◽

M. Donepudi ◽

Z. Younossi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Phase 3 ◽

Treatment Naïve ◽

Post Hoc ◽

Chronic Hepatitis C Patients

Download Full-text

Cost-Effectiveness Of Ombitasvir/Paritaprevir/Ritonavir With Or Without Dasabuvir For The Treatment Of Chronic Hepatitis C Patients Infected With Genotype 1 Or 4 In France

Value in Health ◽

10.1016/j.jval.2016.09.404 ◽

2016 ◽

Vol 19 (7) ◽

pp. A416

Author(s):

G Sroczynski ◽

A Conrads-Frank ◽

N Mühlberger ◽

F Kühne ◽

G Jeanblanc ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Chronic Hepatitis C Patients

Download Full-text

P0788 : Estimating the cost-effectiveness of daclatasvir plus sofosbuvir in treatment-naïve, treatment-experienced and interferon-ineligible/intolerant patients with advanced chronic hepatitis C genotype 1 infection

Journal of Hepatology ◽

10.1016/s0168-8278(15)30991-0 ◽

2015 ◽

Vol 62 ◽

pp. S627-S628

Author(s):

P. McEwan ◽

S. Webster ◽

T. Ward ◽

A. Kalsekar ◽

Y. Yuan ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Treatment Naïve ◽

Download Full-text

Cost-Effectiveness Analysis Of A Personalized Therapy For Genotype 1, Naive, Chronic Hepatitis C Patients In Italy

Value in Health ◽

10.1016/j.jval.2014.08.819 ◽

2014 ◽

Vol 17 (7) ◽

pp. A366

Author(s):

S. Iannazzo ◽

P. Colombatto ◽

F. Bonino ◽

M.R. Brunetto

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Personalized Therapy ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Patients

Download Full-text

1102 THE COST-EFFECTIVENESS OF TELAPREVIR (TVR) IN COMBINATION WITH PEGYLATED INTERFERON-ALFA AND RIBAVIRIN (PR) FOR THE TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS

Journal of Hepatology ◽

10.1016/s0168-8278(12)61114-3 ◽

2012 ◽

Vol 56 ◽

pp. S434 ◽

Author(s):

S. Curtis ◽

S. Cure ◽

S. Gavart ◽

L. Dearden ◽

J. Fleischmann ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Pegylated Interferon Alfa ◽

The Cost ◽

Chronic Hepatitis C Patients

Download Full-text

Efficacy of telaprevir and boceprevir in treatment-naïve and treatment-experienced genotype 1 chronic hepatitis C patients: an indirect comparison using Bayesian network meta-analysis

Current Medical Research and Opinion ◽

10.1185/03007995.2012.734798 ◽

2012 ◽

Vol 28 (11) ◽

pp. 1841-1856 ◽

Author(s):

S. Cure ◽

J. Diels ◽

S. Gavart ◽

F. Bianic ◽

E. Jones

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Bayesian Network ◽

Chronic Hepatitis C ◽

Meta Analysis ◽

Indirect Comparison ◽

Treatment Naïve ◽

Chronic Hepatitis C Patients

Download Full-text

Cost-effectiveness analysis of simeprevir in combination with peginterferon and ribavirin for treatment-naïve chronic hepatitis C genotype 1 patients in Japan

Journal of Medical Economics ◽

10.3111/13696998.2015.1029492 ◽

2015 ◽

Vol 18 (7) ◽

pp. 502-511 ◽

Author(s):

Hiroyo Kuwabara ◽

Kirsten Westerhout ◽

Maarten Treur ◽

Karin Cerri ◽

Joerg Mahlich ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis ◽

Treatment Naïve ◽

Peginterferon And Ribavirin

Download Full-text

A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in Taiwan

The Kaohsiung Journal of Medical Sciences ◽

10.1016/j.kjms.2016.10.008 ◽

2017 ◽

Vol 33 (1) ◽

pp. 44-49 ◽

Author(s):

Pei-Chien Tsai ◽

Ta-Wei Liu ◽

Meng-Hsuan Hsieh ◽

Ming-Lun Yeh ◽

Po-Cheng Liang ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Treatment Naïve ◽

Chronic Hepatitis C Patients

Download Full-text